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Abstract
Introduction: We investigated the association between bone mineral density
(BMD) detected by dual-energy X-ray absorptiometric (DXA) method and blood
pressure (BP) in a large sample of postmenopausal women.
Material and methods: The current study was based on a retrospective analysis
of 586 postmenopausal women with a mean age of 60.8 ±8.8 years, who were
screened for osteopenia or osteoporosis by DXA. Patients with hypertension 
(HT, n = 306) were compared with normotensive (NT, n = 290) individuals. Bone
mineral density results for the femur neck and spine were classified into 3 groups
according to World Health Organization criteria: normal (T score > –1.0 SD),
osteopenia (T score –1.0 to –2.5 SD) and osteoporosis (T score < –2.5 SD). Patients
with osteopenia or osteoporosis (T score < –1.0 SD) were grouped as having low
bone mass (LBM). 
Results: There were no significant differences in femur T score, femur BMD,
femur Z score, spinal T score, spinal BMD and spinal Z score between
hypertensive and normotensive groups. The group of patients with low bone
mass calculated from femur T scores had higher age, systolic BP, duration of
hypertension and duration of menopause, but lower BMI. Similarly, patients
with low spine BMD had higher age and duration of menopause, but lower BMI.
Linear regression analysis showed a significant correlation between systolic BP
and femur BMD and T score values. Furthermore, logistic regression analysis
revealed that hypertension is an independent predictor of spinal osteopenia
and osteoporosis. 
Conclusions: The presence of hypertension is an independent predictor of spinal
low bone density in Turkish women after menopause.
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Introduction
The association between high blood pressure (BP) and abnormalities
in calcium metabolism has been previously investigated in experimental,
clinical and epidemiological studies but the existing evidence is inconclusive
[1-6]. In several studies it has been consistently reported that sustained
hypercalciuria as a result of high BP may be the underlying mechanism
that explains the pathophysiology of hypertensive bone loss [7-9].
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Furthermore, hypertension is presumed to be
related to alterations in calcium metabolism leading
to increased calcium losses, secondary activation
of the parathyroid gland, and increased movement
of calcium from bone [1, 4]. Such long-lasting
disturbances in calcium metabolism may consti  -
tute one of the mechanisms involved in the
development of excessive age-related BMD
reduction. In addition, it has been suggested that
calcium loss related to high BP may be due to
a defect in the kidney’s ability to handle calcium.
Finally, some studies have also suggested that
increased angiotensin II levels in hypertensive
patients have a harmful effect by increasing bone
resorption and inhibiting mineralization [10-12].
Consistent with these results, in some studies,
intake of calcium has been shown to correlate
inversely with BP and to have a beneficial effect in
human hypertension [13, 14]. In a large cohort of
British women, Cappuccio et al. found that femoral
neck BMD detected by the dual-energy X-ray
absorptiometric (DXA) method was inversely related
to the highest tertile of systolic and diastolic BP
values [4]. However, Mussolino et al. reported that
there were no significant associations between
BMD and hypertension in men or women of African
American or white ethnicity by using the National
Health and Nutrition Examination Survey (NHANES)
data [15].
To the best of our knowledge, the association
between blood pressure and bone mass has not
been studied previously in the Turkish population.
Therefore, in a large national sample of post  -
menopausal women in whom both osteo  po  rosis
and hypertension are highly prevalent, we aimed
to determine femoral neck and L2-L4 spine BMD
values detected by the DXA method and compare
these parameters in normotensive and hyper  -
tensive groups. 
Material and methods
Population sample
The current study, which was carried out in the
departments of Cardiology and Physical Medicine
of Düzce University Faculty of Medicine, was based
on a retrospective analysis of 750 consecutive
individuals screened for osteopenia or osteoporosis
by dual energy X-ray absorptiometry (DXA) between
February 2005 and May 2008. In the final analytic
sample, 586 postmenopausal women (with a mean
age of 60.8 ±8.8 years) without any exclusion
criteria were included in the study. Exclusion criteria
were known chronic infectious or inflammatory
disease, known coronary heart disease, thyroid
diseases, severe liver or renal disease, neoplasm,
haematological disorders, taking anticoagulant
therapy, and physical inactivity. In addition, patients
taking hormone replacement therapy (HRT) were
also excluded. Postmenopausal status was
determined by a “no” response to the question,
“Have you had a period in the past 12 months?”
Prior medical histories, including comorbidities that
might affect bone density, were recorded.
Approximately one out of five patients in each
group have been treated with alendronate (70 mg),
risedronate (35 mg) or raloxifene (60 mg) along
with calcium (1000 mg) and vitamin D (0.5 μg).
Diuretic, antihypertensive agents and steroid use,
known to affect bone mass, were also recorded.
Anthropometric and biochemical data were
collected from the patients’ physical medicine files
and laboratory records.
The Institutional Review Board of the Düzce
University Faculty of Medicine approved the study,
a waiver of consent was granted and patient
identity was protected.
Measurements of risk variables
Hypertension was defined as blood pressure 
≥ 140 mmHg and/or ≥ 90 mmHg, and/or use of
antihypertensive medication [16]. Blood pressure
was measured in the sitting position on the right
arm, and the mean of two recordings at least 3 min
apart was recorded. Body mass index (BMI) was
computed as weight divided by height squared
(kg/m2). In a combined assessment of leisure-time
and work activity, during last year, it was
categorized into four grades of increasing activity
via a questionnaire in which the participant,
assisted by the survey physician, assigned a grade
for her activity. The four levels were: (1) being
almost entirely inactive or engaging in light physical
activity, 2 h per week (e.g. reading, watching
television); (2) engaging in light physical activity for
2-4 h per week (e.g. walking, cycling, washing
dishes, light gardening, light physical exercise); 
(3) engaging in light physical activity for 4 h per
week or more vigorous activity for 2-4 h per week
(e.g. brisk walking 3-4 mph, fast cycling, heavy
gardening, sports that cause perspiration or
exhaustion); and (4) engaging in vigorous physical
activity for 4 h per week, regular heavy exercise, or
competitive sports several times per week. Level 1
was considered physically inactive, level 2 was
considered a low level of physical activity, and levels
3 and 4 together were considered a moderate to
high level of physical activity [17].
Bone mineral density scans
Bone mineral density (g/cm2) was measured 
for the lumbar spine (L2 to L4) and proximal femur
using a GE Lunar DPX-NT PRO (Lunar Corp, Adison,
WI, USA) by DXA scanning. Bbone mineral density
was determined according to standard Lunar
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protocols. Bone mineral density was expressed in
g/cm2 and as peak bone mass percentage in
normal subjects (T-score) depending on the
software used in the device. Results for the femur
neck and lumbar spinal were classified into 
3 groups according to World Health Organization
criteria: normal (T score > –1.0 SD), osteopenia 
(T score –1.0 to –2.5 SD) and osteoporosis (T score 
< –2.5 SD). Patients with osteopenia or osteoporosis
(T score < –1.0 SD) were grouped as having low
bone mass.
Statistical analysis
All continuous variables were tested for
skewness. The distribution of all variables was
normal. The continuous parameters were presented
as mean ± standard deviation. Comparisons of
demographic, clinical and laboratory characteristics
of the patients were performed using independent
sample  t-test or one-way ANOVA test for
continuous variables. Categorical variables were
compared with the χ2 test. Logistic regression
model with enter method was used to evaluate
associations between hypertension and femur BMD
or spine BMD. Linear regression analysis was
performed to examine the association between T
scores and bone mass covariates including
hypertension. Multivariate logistic regression
analysis was used to assess the independent
association of BMD with hypertension. Statistical
analyses were carried out using SPSS 13.0 for
Windows and a p-value < 0.05 was considered
significant
Results
In total, 586 subjects (mean age 60.8 ±8.8 years,
BMI 30.9 ±5.3 kg/m2) were analysed. 52.2% of them
had hypertension. Demographic, clinical and some
laboratory variables of the subjects with and
without HT are shown in Table I. The number of
patients taking different agents of treatment for
osteoporosis was similar in both groups (Table I).
Hypertensive patients were older and had
significantly higher BMI, duration of menopause,
and systolic and diastolic BP values. Bone mineral
density variables were also similar between the two
groups (Table I). 
Linear regression analysis showed that
hypertension, age, BMI, smoking status and
physical activity were significant correlates of femur
or spinal BMD and T scores (Figure 1). Furthermore,
logistic regression analysis was used to identify
independent determinants of LBM (Table II). The
covariates considered were hypertension, age,
physical activity, and smoking status and BMI.
Hypertension was found to be an independent
predictor of LBM (osteoporosis and osteopenia)
measured from the spine. On the other hand, only
age and BMI were left as independent predictors
of LBM measured from the femur neck. 
Moreover, the study population was further
divided into two groups as normal (n = 224) and
low bone mass (LBM) according to femur bone
mass and/or spine bone mass values. When
compared with normal bone mass (NBM) for femur,
the group with LBM (n = 362) had higher age,
systolic BP, duration of hypertension, duration of
menopause and number of births, but lower BMI
(Figure 2). Similarly, when compared with NBM for
spine (n = 182), the group with LBM (n = 403) had
higher age, duration of menopause and number of
births, but lower BMI. However, no independent
relationship was found between these parameters
and systolic or diastolic BP in logistic regression
analysis.
Discussion
In the present study, femur BMD, femur T score,
femur Z score, spine BMD, spine T score and spine
Z score values were similar in both normotensive
and hypertensive groups. Hypertension was found
to be an independent predictor of osteoporosis and
osteopenia measured from the spine. When BMD
was measured from the femur neck, only age and
BMI were left as independent predictors of LBM. 
Trabecular bone (lumbar spine, os calcis) has
been shown to be more sensitive to metabolic
changes compared with cortical bone (femoral neck,
distal radius) [18]. The association between
hypertension and osteopenia has been shown to
be site specific [19-21]. Furthermore, there are
differences in the timing of bone loss in healthy
women, with trabecular bone diminishing with
every decade of life but cortical bone levels being
similar in the third, fourth, and fifth decades [22].
As there are essential differences in response to
environmental (including hormonal or nutritional)
factors between the cortical and trabecular part of
bone structure, as in our study, it would seem more
logical that measurement of both cortical (at the
femoral neck) and trabecular bone (lumbar spine)
is necessary.
The link between hypertension and abnor  ma  -
lities in calcium metabolism that lead to increased
calcium loss from bone in adults has been studied
previously but the results differ according to the
ethnic groups and are inconclusive [4, 5, 10, 13, 
19-24]. Tsuda et al. compared the BMD of 31
hypertensive Japanese women to 14 normotensives
and reported inverse correlations between lumbar
spine BMD and systolic blood pressure (SBP) [23].
In another study, Gotoh et al. reported that lumbar
spine BMD provides an index of whole calcium
balance, and implied that elevated blood pressure
is associated with abnormalities in calcium
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Parameters Normotensive subjects Hypertensive patients
(n = 280) (n = 306)
Age [years] 58.9 ±8.6 62.4 ±8.7‡
Body mass index [kg/m2] 30.2 ±5.2 31.5 ±5.3†
Systolic blood pressure [mmHg] 121.0 ±11.4 149.4 ±15.3‡
Diastolic blood pressure [mmHg] 76.3 ±8.2 90.4 ±9.1‡
Serum calcium [mg/dl] 9.5 ±0.5 9.4 ±0.5
Serum phosphorus [mg/dl] 3.7 ±0.5 3.8 ±0.7
Bone mineral density (BMD) femur [g/cm2] 0.83 ±0.12 0.82 ±0.12
Femur T-score  –1.16 ±1.02 –1.24 ±1.03
Femur Z-score  –0.21 ±0.94 –0.08 ±0.82
Bone mineral density (BMD) spine [g/cm2]  0.95 ±0.16 0.94 ±0.18
Spine T-score –1.51 ±1.31 –1.59 ±1.42
Spine Z-score –0.65 ±1.28 –0.52 ±1.31
Low bone density for femur [%] 56.8 66.4¶
Low bone density for spine [%] 66.1 71.2
Blood pressure medication [%] – 38
Current smokers [%]  11.1 5.9
Package-years  15.7 ±12.6 12.5 ±7.8
Physical activity level [%] 
Low 44.7 42.8
Moderate 48.6 50.0
High          5.4 6.9
Duration of hypertension [years] – 7.7 ±6.8
Years since menopause  12.1 ±9.4 15.3 ±9.1¶
Presence of diabetes mellitus [%] 14.3 16.4
Therapy for osteoporosis [%]  22.8 21.9
Alendronate use (n)4 9 4 5
Risedronate use (n)1 2 1 8
Raloxifene use (n)3 4
‡p < 0.001, vs. normotensive group, †p < 0.005, vs. normotensive group, ¶p < 0.05, vs. normotensive group
Table I. Comparisons of demographic, clinical and laboratory characteristics of groups
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Figure 1. Associations between femur BMD and T scores of hypertensive subjects and systolic blood pressure (BP)
values in linear regression analysis 
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metabolism [13]. Similarly, Afghani et al. reported
that hypertensive women had significantly lower
bone mineral content (BMC) compared with
normotensive women and SBP was significantly,
independently and inversely related to BMC, but
not BMD, in premenopausal women [22]. Their
analysis was restricted to a small population of
Hispanic women (9 hypertensive and 24 normal)
and the findings may not be generalizable to other
ethnic groups. In a large British cohort, Cappuccio
et al. studied the relation between bone mass and
blood pressure in white postmenopausal elderly
women. They found femoral neck BMD to be
inversely related to systolic and diastolic blood
pressure, but only with the highest BP quartile [4].
Contrary to our study, they also restricted their
analysis to the neck of the femur, so they could not
conclude about this association at different sites.
Likewise, a population-based study of 6886 Swedish
women (aged 50 to 59 years) reported that bone
density was positively associated with systolic BP .
Lidfeldt et al. revealed that the relationship was
most evident among postmenopausal women
without hormone replacement therapy. However,
they did not control for potential confounders such
as BMI [5]. Our findings are concordant with these
results.
Contrary to these findings, Mussolino et al.
reported that no relationship existed between
hypertension and proximal femur BMD after
Table II. Independent predictors of osteoporosis and osteopenia (according to BMD values measured from the spine)
in multivariate logistic regression analysis
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Figure 2. Comparisons of blood pressure values in groups (according to the measurements of femur or spine bone
mineral density)
Independent predictors of osteoporosis
Parameters OR 95% Confidence interval Value of p
Lower Upper
Age 1.079 1.052 1.107 < 0.001
Body mass index 0.91 0.876 0.945 < 0.001
Smoking status 0.473 0.246 0.412 0.025
Physical activity 1.455 0.99 2.139 0.057
Presence of hypertension 0.532 0.355 0.798 0.002
Independent predictors of osteopenia
Parameters OR 95% Confidence interval Value of p
Lower Upper
Age 1.079 1.055 1.105 < 0.001
Body mass index 0.904 0.868 0.941 < 0.001
Smoking status 0.752 0.435 1.639 0.473
Physical activity 1.548 1.05 2.281 0.027
Presence of hypertension 0.61 0.408 0.912 0.016
Femur NBM Femur LBM Spine NBM Spine LBM
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controlling for body mass index and other potential
confounders (age, smoking, alcohol consumption,
physical activity and so on) in one of a few large-
scale studies of hypertension and BMD [15].
Moreover, they previously reported that there was
no significant association between BMD and
hypertension in the NHANES study [25]. It is clear
that diagnosis of LBM changes according to the site
of DXA analysis. In these studies the authors only
measured BMD from the femur neck and they could
not find any association between hypertension and
BMD. In our study, hypertension was found to be
an independent predictor of LBM measured only
from the spine. 
Sustained hypercalciuria as a result of high BP
was speculated as the underlying mechanism that
explains the pathophysiology of hypertensive bone
loss [7-9]. Primary hypertension is related to
alterations in calcium metabolism leading to
increased calcium losses, secondary activation of
the parathyroid gland, and increased movement
from bone [1-5]. Such long-lasting disturbances in
calcium metabolism may constitute one of the
mechanisms involved in the development of
excessive age-related BMD reduction. If these
disturbances persist for many years, they may
additionally promote female senile osteopenia. On
the other hand, Perez-Castrillon et al. proposed that
because increased angiotensin II levels have
a harmful effect on bone mass by increasing bone
resorption and inhibiting mineralization, angio  -
tensin-converting enzyme (ACE) inhibitors or
angiotensin II-receptor blockers may be useful in
the treatment of osteoporosis in hypertensive
women [26]. By contrast, the number of
hypertensive subjects who have been taking
antihypertensive drugs such as thiazides and ACE
inhibitors, which could positively interfere with
calcium metabolism, was not specified in the
analysis of many studies [26, 27].
These conflicting results in previously reported
studies might be explained at least in part by
different patient selections (such as age, ethnicity,
sample size, inclusion of patients with
comorbidities, different extent and aetiology of
osteoporosis or hypertension) and different
diagnostic methods or criteria. In the present study,
we applied strict rules in the selection of the study
population and excluded patients with confounding
factors, such as HRT use, especially affecting bone
mass. 
Approximately one out of five subjects in each
group had been treated for osteoporosis with
various medications, all of which are believed to
have different effects on the patient’s BMD. It is
possible that the heterogeneity of the two groups
would confound the results of the study. Our
analysis is restricted to postmenopausal women
aged 50 years and older; therefore, the findings are
not generalizable to men or younger women. In
addition, a source of possible bias is misclassi  -
fication because of assessment of hypertension at
a single visit in the present study (as in the NHANES
III study). Particularly, it should be emphasized that
the cross-sectional design of this study precludes
any conclusions on cause-effect relationships
between blood pressure and bone mineral status
in women. Therefore, a prospective designed study
which has a larger sample size in addition to the
measurement of biochemical indices of bone
mineral metabolism would need to be employed to
evaluate in more detail the relationship between
BP and BMD. 
In conclusion, the present study is the first to
evaluate the association between hypertension and
bone mineral density in postmenopausal Turkish
women. The presence of hypertension was found
to be an independent predictor of low bone density. 
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